Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30344101.
- Also identified by DOI 10.1016/j.stem.2018.10.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hundreds of clinics in India offer unproven stem cell therapies despite having remarkably stringent guidelines and regulations for fraudulent advertisements and clinical practice. We discuss the challenges with current regulations, how a recently proposed amendment may further legitimize unproven stem cell therapies, and discuss paths forward in a global context.
Medical subject headings
- Stem Cell Transplantation